spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Vasogen 

 HSMN NewsFeed - 9 Dec 2016
Lilly Announces Detailed Results of Solanezumab Phase 3 EXPEDITION3 Study at the Clinical Trials on Alzheimer's Disease (CTAD) 2016 Meeting
Biopharmaceuticals Neurology
 HSMN NewsFeed - 14 Sep 2016
European Commission Approves CABOMETYX(TM) (cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carcinoma Following VEGF-Targeted Therapy
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 12 Dec 2012
Lilly Provides Update on Next Steps for Solanezumab
Biopharmaceuticals Neurology
 HSMN NewsFeed - 19 Oct 2010
Integra LifeSciences Features Integra(TM) Flow Regulating Valve, Mini at Congress of Neurological Surgeons Annual Meeting
Devices Neurosurgery
 HSMN NewsFeed - 17 Jun 2008
Elan and Wyeth Announce Encouraging Top-line Results from Phase 2 Clinical Trial of Bapineuzumab for Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 14 Apr 2008
Vasogen Announces Implementation of Strategic Restructuring Plan
Biopharmaceuticals
 HSMN NewsFeed - 3 Mar 2008
Vasogen Provides Update on ACCLAIM II Program
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 17 Sep 2007
Vasogen Plans Confirmatory Study of Celacade(TM) in Chronic Heart Failure to Support U.S. Regulatory Approval
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 27 Jun 2007
Vasogen Reports on Outcome of FDA Meeting
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 20 Jun 2007
DexCom(TM) Appoints Terrance H. Gregg as CEO
Devices Personnel
 HSMN NewsFeed - 20 Jun 2007
Chris Waddick Appointed President and CEO of Vasogen
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Apr 2007
Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade(TM) in the European Union
Biopharmaceuticals Devices Cardiology
 HSMN NewsFeed - 11 Apr 2007
Vasogen Announces Senior Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Mar 2007
Vasogen Appoints Terry H. Gregg President & CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Oct 2006
Vasogen's ACCLAIM Trial of Celacade(TM) in Heart Failure Presented at the Canadian Cardiovascular Congress
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 13 Sep 2006
Vasogen's Celacade(TM) Shown to Significantly Reduce Time in Hospital in Prime Heart Failure Target Population
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 17 Jul 2006
Endovasc Cites Favorable Market Conditions for its Liprostin Drug
Biopharmaceuticals
 HSMN NewsFeed - 26 Jun 2006
Vasogen Announces Initial Results from Phase III ACCLAIM Trial in Chronic Heart Failure
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 23 May 2006
Cardiva Medical, Inc. Completes $13.99 Million Series C Financing
Devices Interventional Venture Capital
Return to NewsFeed  

 Additional items found! 23

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 23 additional stories matching:
Vasogen
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.